CD40LG and Alzheimer disease: Linard and colleagues [35] surveyed a prospective cohort and reported that among APOE-ε4 carriers–characterised by the authors as having a high frequency of HSV1 reactivation—those positive for IgM or with high IgG levels, had an increased risk of AD.